CymitQuimica logo

CAS 105816-05-5

:

L-Nateglinide

Description:
L-Nateglinide is an oral hypoglycemic agent primarily used in the management of type 2 diabetes mellitus. It belongs to the class of medications known as meglitinides, which stimulate insulin secretion from the pancreatic beta cells in response to meals. This action helps to lower blood glucose levels, particularly postprandial (after eating). L-Nateglinide has a rapid onset of action, making it effective for controlling blood sugar spikes after meals. Its chemical structure includes a specific configuration that contributes to its pharmacological activity, and it is characterized by a relatively short half-life, necessitating multiple doses throughout the day. The substance is typically administered in conjunction with diet and exercise to improve glycemic control. Common side effects may include hypoglycemia, gastrointestinal disturbances, and weight gain. As with any medication, it is essential for patients to consult healthcare professionals for personalized advice and monitoring while using L-Nateglinide.
Synonyms:
  • L-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, trans-
  • L-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]- (9CI)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.